Business
Bell Potter just upgraded the target price on ASX healthcare stock
Image source: Getty Images
Broker Bell Potter has issued a new report on ASX healthcare stock Neuren Pharmaceuticals Ltd (ASX: NEU).
It has maintained its buy rating and also increased its target price.
Neuren Pharmaceuticals is a biopharmaceutical company specialising in developing new…
Continue Reading
-
Noosa News12 hours agoBondi Beach terror attack: Police investigate threat against Westfield North Lakes in Queensland
-
General23 hours agoICAC investigating University of Wollongong as chancellor grilled at Inquiry
-
Noosa News22 hours agoE-Scooter accident | Noosa Today
-
General21 hours agoOutback Farm stars finish first barley harvest at Central Australian farm